ChromaDex completes pterostilbene UV trial

Published: 10-Oct-2014

US naturals firm ChromaDex has announced the completion of an animal skincare study of pterostilbene, which the firm says shows that the substance prevents skin damage from UV exposure

You need to be a subscriber to read this article.
Click here to find out more.

US naturals firm ChromaDex has announced the completion of an animal skincare study of pterostilbene, which the firm says shows that the substance prevents skin damage from UV exposure.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.

You may also like